Genetics and Epigenetics of Cholangiocarcinoma: Status 2019

DNA Methylation

[GEO](https://www.ncbi.nlm.nih.gov/gds):  (Cholangiocarcinoma) AND "Homo sapiens"[porgn:__txid9606] 
* [GSE49656](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49656): 450K, 32 case vs 4 normal, IDAT not available[ code](https://github.com/Shicheng-Guo/GEO/tree/master/GSE49656)
* GSE44965	methyl CpG-immunoprecipitation (MCIp)
* GSE60446	450K in TFK-1 and HuCCT1
* GSE49656	450K in 32 CCA and 4 normal
* GSE32079	450K in 40 CCA
* GSE38860	27K in 28CCA and 6 adjacent
* [GSE38860](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38860): 27K, 28 case vs 6 normal, IDAT not available[ code](https://github.com/Shicheng-Guo/GEO/tree/master/GSE38860)


* intrahepatic (iCCA), perihilar (pCCA), or distal (dCCA)

ncRNA and lncRNA

1. [GSE103909](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103909):  9 CCA + 9 adjacent + 3 Normal  [GSE103909.R](GSE103909.R)






### Method
* Sample control: LINE-1
* Study design: Case-Control
* Sex control: RBMY1F
* Positive control: LINE-1
* Negative control: CHRM

### Precision Medicine of Cholangiocarcinoma: Status 2019

